SHANGHAI, July 22 /PRNewswire-Asia/ -- Since the implementation of Express Customs Clearance on a trial basis a month ago for Sundia MediTech Company and 2 other CRO companies in Zhangjiang Hi-Tech Park in Shanghai, the customs clearance time for Sundia's CRO shipments has been shortened from 3 days to 1 day on average, according to Mr. Wei Zhengrong, Logistics Manager of Sundia.
In light of the rapid growth of the CRO industry in China, the government is paying more attention to creating an attractive environment for the operation of CRO companies in the country. Because the timing of CRO shipments is critical for successful CRO operations, on June 22, Shanghai Pudong Customs, Pudong International Airport Customs and Zhangjiang Group Co. selected Sundia and 2 other CRO companies from Zhangjiang Hi-Tech Park for a trial operation of Express Clearance, which implements various measures to speed up customs clearance processes. Meanwhile, as part of the effort, trained customer service professionals at Shanghai Customs have been assigned to assist CRO companies to ensure a smooth declaration and clearance process. This new customs clearance model will be implemented for more CRO companies after the successful trial.
"With these efforts from Chinese customs, the shipments to our clients are delivered without any delay at customs. The Express Custom Clearance privilege granted to Sundia greatly benefits our clients with high-quality and effective service on a timely basis," said Dr. Wang Xiaochuan, Sundia's Chairman and CEO.
About Sundia MediTech
Sundia MediTech Company is a leading integrated pharmaceutical contract research organization (CRO) company based in Shanghai, China. It was founded in Shanghai in 2004 by a group of veterans of the US pharmaceutical industry to provide R&D outsourcing services to biotech and pharmaceutical companies worldwide, ranging from chemical services, medicinal chemistry, biological service, new technology platforms and services, and pharmaceutical development.
|SOURCE Sundia MediTech Company|
Copyright©2009 PR Newswire.
All rights reserved